We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pulmonary Veins Ablation Alone Sufficient for Persistent AF

By HospiMedica International staff writers
Posted on 17 Sep 2014
Catheter ablation of the pulmonary veins alone can improve outcomes in around half of those suffering from persistent atrial fibrillation (AF), according to a new study. More...


Researchers at Southlake Regional Health Center (Newmarket, Canada), the German Heart Center (Munich, Germany), and other institutions participating in the STAR AF 2 study randomized 589 patients (median age 58, 22% women) to pulmonary vein isolation (PVI, 64 patients) alone, PVI plus ablation by complex fractionated electrogram (PVI-CFE, 254 patients), or PVI plus empiric linear ablation of lesions in the left atrium (PVI-lines, 250 patients).


The results showed that successful PVI was achieved in 97% of all patients with no differences between groups. However, procedural time was significantly shorter for the PVI alone group (167 minutes) compared to the PVA-CFE (229 minutes) and PVI plus lines (223 minutes) groups. The study also found that patients did not benefit from further ablation, since it increased treatment time and did not reduce AF recurrence. The study was presented at the European Society of Cardiology (ESC) congress, held during August-September 2014 in Barcelona (Spain).

“Among patients with persistent atrial fibrillation, freedom from recurrent atrial fibrillation was achieved in 59% of participants with PVI alone. Additional CFE or lines ablation added to procedure/fluoroscopy time, without improving freedom from atrial fibrillation,” said lead author and study presenter Atul Verma. “The results may ‘force’ a change in guideline thinking and a shift in practice to shorter and more effective pulmonary vein ablation without the addition of other ablation.”

PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of AF. Although the procedure initially involved ablation with a catheter directly in the pulmonary veins, isolating the pulmonary veins by applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF have not been suppressed by antiarrhythmic drugs, or who do not wish to take long-term antiarrhythmic or anticoagulation medications.

Related Links:

Southlake Regional Health Center
German Heart Center



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.